,СЛОВО,abstract,infections,in,childhood,play,an,essential,role,the,pathogenesis,of,cognitive,and,psycho-emotional,disorders,one,possible,mechanisms,these,impairments,is,changes,functional,properties,nmda,ampa,glutamate,receptors,brain,we,suggest,that,bacterial,during,early,life,period,which,critical,for,excitatory,synapse,maturation,can,affect,subunit,composition,present,study,investigated,effect,repetitive,lipopolysaccharide,lps,intraperitoneal,ip,administration,25 μg/kg/day,on,p14,16,18,mimicking,infectious,disease,expression,subunits,young,rats,revealed,a,substantial,decrease,glun2b,hippocampus,at,p23,using,western,blot,analysis,real-time,polymerase,chain,reaction,assay,moderate,were,also,found,glun1,glun2a,glua1,mrna,lps-treated,exhibited,decreased,exploratory,locomotor,activity,open,field,test,impairment,spatial,learning,morris,water,maze,behavioral,accompanied,by,significant,reduction,long-term,hippocampal,synaptic,potentiation,our,data,indicate,lps-treatment,alters,ionotropic,receptor,gene,disturbs,plasticity,behavior,prolonged,exposure,to,manganese,mn,may,lead,toxic,effects,central,nervous,system,cns,underlying,neuronal,death,from,are,not,well,understood,but,undoubtedly,involve,inflammatory,processes,aim,this,was,explore,long-lasting,intranasal,focusing,catecholamine,dopamine,norepinephrine,levels,striatum,it,instillation,mncl2,solution,once,day,90,days,leads,impaired,movement,gait,observed,concentration,increased,30,%,220,24,dopac,35,reduced,190,with,simultaneously,observation,cytokine,both,assayed,cytokines,il-1β,tnf-α,there,3-fold,increase,iba-1,2-fold,nfκb,dramatic,ikb,taken,together,high,dose,induces,neuroinﬂammation,neurotransmission,disturbance,specific,each,studied,region,shortly,after,syphilis,appeared,europe,time,columbus’,voyage,new,world,big,pox,as,often,known,became,serious,issue,russia,diagnosis,treatment,prevention,members,russian,royal,family,made,aware,adolescence,onward,czar,peter,great,had,many,sexual,contacts,could,have,contracted,any,number,sexually,transmitted,diseases,stds,quite,common,his,era,nevertheless,contributions,analyzed,available,sources,contemporary,doctors,later,medical,analyses,reveal,no,evidence,he,or,other,std,most,likely,died,acute,renal,failure,due,urinary,tract,obstruction,upper,respiratory,world's,etiologic,agents,behind,urtis,fact,diverse,set,pathogens,such,influenza,parainfluenza,adenovirus,rhinovirus,others,more,than,200,be,involved,differential,viral,sometimes,complicated,their,diversity,similarity,clinical,presentation,work,devoted,development,method,enables,simultaneous,detection,six,urti,iav,ibv,rsv,hadv,hpiv2,hpiv3,antibody,microarray,technology,utilized,accomplish,preparation,protein,microchip,creation,produced,characterized,selected,approximately,50,monoclonal,antibodies,aforementioned,optimal,pair,created,its,core,working,conditions,optimized,balance,between,convenience,maximal,sensitivity,mind,one-step,approach,developed,accomplishing,elisa-like,sandwich,interaction,manufactured,reference,strains,used,establish,lower,limits,lod,025 ng/ml,total,viruses,ranged,1,2 ng/ml,slightly,better,those,standard,elisa,inferior,pcr,overall,believe,good,alternative,existing,methods,allowing,relatively,quick,overnight,inexpensive,screening,several,design,conducive,further,panel,expanded,include,fullerene,c60,has,potential,application,various,fields,biomedicine,including,reactive,oxygen,species,ros,scavenging,inhibiting,tumours,inactivating,bacteria,elaboration,diagnostic,targeted,drug,delivery,tools,however,hydrophobicity,molecule,impedes,practical,use,therefore,actuality,research,functionalisation,fullerenes,leading,amphiphilic,derivatives,remains,important,water-soluble,carboxylated,derivative,c60ccooh23,extensive,biomedical,investigation,compound,namely,binding,human,serum,albumin,hsa,radical,diphenylpicrylhydrazyl,dpph,photodynamic,cytotoxicity,embryonic,kidney,hek293,cell,line,erythrocytes',haemolysis,platelet,aggregation,genotoxicity,peripheral,mononuclear,cells,pbmc,conducted,moreover,dynamic,structural,characteristics,c60ccooh23–h2o,binary,obtained,molecular,md,size,distribution,associates,measured,aims,single-center,retrospective,evaluated,whether,level,different,checkpoint,molecules,bone,marrow,biopsies,course,patients,myelodysplastic,syndrome,mds,results,consecutive,cohort,55,treated,center,2003,2018,technique,able,detect,following,antigens,pd-1,pd-l1,pd-l2,lag-3,gal-9,tim-3,cd80,association,3-year,relapse-free,survival,time-to-progression,intensive,100%,cases,follow-up,progression,seen,729%,521%,low,p004,ctla4,ligands,co-expressed,majority,general,ligand,associated,incidence,672%,progressed,while,group,only,333%,p0059,tim3,blasts,risk,according,ipss,ipss-r,scales,conclusions,preliminary,underlined,heterogeneous,immune,warrants,studies,define,heterogeneity,develop,approaches,background,covid-19,pandemic,broadly,disrupted,non-invasive,stimulation,nibs,rapid,onset,societal,disruption,evolving,regulatory,restrictions,allowed,systematic,planning,how,continue,throughout,restarted,abated,urgency,provide,intervention,neurological,mental,health,indications,catalyst,fundamental,dampened,parallel,efforts,address,life-threatening,aspects,rather,need,heightened,mitigate,consequences,related,objective,facilitate,re-establishment,access,services,operations,current,future,outbreaks,discuss,framework,balancing,importance,safety,considerations,addressing,needs,all,stakeholders,focus,transcranial,magnetic,tms,intensity,electrical,tes,-,direct,tdcs,alternating,tacs,consensus,paper,provides,guidelines,practices,managing,reopening,clinics,laboratories,through,immediate,ongoing,stages,document,reflects,experts,domain-relevant,expertise,spanning,basic,–,international,perspective,outline,resources,optimization,accommodations,demographics,model,based,three,phases,impact,11-step,checklist,removing,streamlining,in-person,protocols,incorporating,telemedicine,covid-19-associated,adverse,events,proposed,recommendations,implementing,social,distancing,sterilization,equipment,positive,populations,comorbidities,regarding,resource,outlined,specifically,sub-populations,pediatric,stroke,addiction,elderly,numerous,case-examples,across,described,conclusion,evident,urgent,maintain,anticipating,waves,robust,structured,strategy,anticipated,challenges,maintaining,scientific,rigor,genetic,markers,determine,prognosis,multiple,sclerosis,ms,still,limited,galanin,polymorphism,rs948854,been,demonstrated,earlier,objectives,confirm,findings,distinct,previously,candidates,stratification,assess,rate,severity,score,msss,age,armss,along,index,pi,minor,allele,confirming,proportion,msss  5,among,g,carriers,genotypes,ag,gg,compared,aa,genotype,furthermore,correlated,value,late,years,collectively,support,contribution,summary,purpose,describe,analyze,patient,recurrent,idiopathic,exudative,polymorphous,vitelliform,maculopathy,aepvm,followed,detail,propose,algorithm,observational,adult,male,diagnosed,who,two,relapses,12-month,eight,initial,review,charts,multimodal,imaging,electrophysiology,repeatedly,underwent,complete,ophthalmic,examinations,best-corrected,visual,acuity,testing,bcva,slit-lamp,fundus,digital,photography,time-domain,optical,coherence,tomography,oct,2009,stratus,carl,zeiss,meditec,usa,spectral-domain,2017–2018,spectralis-oct,heidelberg,engineering,germany,autofluorescence,faf,fluorescein,angiography,fa,indocyanine,green,icga,hra2,microperimetry,mp-1,microperimeter,nidek,japan,laser,flare,photometry,kowa,fm-600,performed,main,outcome,measures,features,rare,case,report,25-year-old,caucasian,typical,serous,neuroepithelial,detachment,irregular,retinal,elevations,ophthalmoscopically,resembling,folds,subsequent,subretinal,accumulation,characteristic,yellow–white,deposits,rarely,even,yet,reported,indocyanine-,fluorescein-negative,intraretinal,cystic,optic,disc,hyperfluorescence,choroidal,thickness,lack,recovery,very,slow,anatomical,improvement,bimonthly,evaluation,sd-oct,informative,demonstrating,evolution,pathological,signs,chronic,condition,uncertain,outcomes,variable,presentations,depending,stage,manifestations,pathologic,process,overlap,should,occurs,slowly,if,recommended,allogeneic,hematopoietic,transplantation,hct,high-risk,t,lymphoblastic,leukemia,t-all,without,hla-identical,donor,haploidentical,haplo-,becoming,source,stem,donation,scarce,predictive,factors,setting,identified,122,adults,20%,female,median,31,range,68,haplo-hct,post-transplantation,cyclophosphamide,ptcy,2010,2017,duration,living,23,months,2-year,incidences,relapse,nonrelapse,mortality,45%,21%,respectively,leukemia-free,lfs,os,graft-versus-host,grfs,34%,42%,27%,highly,influenced,status,being,49%,55%,first,remission,cr1,50%,second,cr,cr2,8%,12%,active,multivariate,negatively,affected,whereas,encouraging,challenging,particularly,when,despite,limitation,small,sample,type,conditioning,calling,into,question,body,irradiation-based,myeloablative,hiv,heavy,drinking,smoking,pro-inflammatory,coronary,heart,chd,interventions,reduce,alcohol,hiv-positive,people,inflammation,varenicline,cytisine,proven,therapies,cessation,consumption,comparative,efficacy,tested,nor,effectiveness,describes,protocol,studying,partial,agonists,ethanol,tobacco,elimination,russians,st,four-arm,parallel-group,randomized,controlled,trial,comparing,nicotine,replacement,therapy,nrt,recruiting,four,hundred,smokers,interested,cutting,down,and/or,petersburg,participants,randomly,assigned,receive,either,varenicline  nrt,placebo,placebo  active,cytisine  nrt,evidence-based,counseling,medication,past,month,primary,craving,2,cigarettes,per,3,7-day,point,prevalence,abstinence,addresses,paucity,guide,here,evaluate,mast,infection,a/h5n1,virus,immunized,mice,cba,intramuscularly,formalin-inactivated,a/vietnam/1194/2004,h5n1nibrg-14,h5n1,samples,7,12,14,21,immunization,infected,intranasally,a/indonesia/5/2005,h5n1idcdc-rg2,half,animals,receiving,mixture,antihistamines,67%,vaccinated,protected,lethality,43%,pbs-immunized,up,85%–95%,immunohistochemical,examination,cd117,staining,lungs,larger,quantity,activated,mock-immunized,histamine,blood,experimental,involvement,they,produce,incomplete,formation,response,vaccination,mismatch,vaccine,gestational,methylazoxymethanol,acetate,mam,produces,offspring,phenotype,relevant,schizophrenia,positive-,negative-like,symptoms,deficits,dopaminergic,dysfunction,abnormalities,show,prenatally,17,display,d3,prefrontal,cortex,pfc,nucleus,accumbens,d2,exclusively,change,perfusion,circle,willis,paralleled,enlargement,lateral,ventricles,detected,resonance,mri,techniques,peripubertal,non-euphoric,phytocannabinoid,cannabidiol,30 mg/kg,postnatal,pnd,19,39,reverse,exposed,i,up-regulation,partially,prevented,haloperidol,06 mg/kg/day,ii,regional,flow,modelling,predicted,bind,preferentially,where,act,agonist,conformation,ionic-lock,conserved,gpcrs,demonstrate,altered,transcript,suggesting,might,contribute,represent,unexplored,target,antipsychotic,timing,immunosuppressive,combination,transplant,haplo-hsct,standardized,schedules,immunosuppression,509,4,tacrolimus,n  215,cyclosporine,csa,mycophenolate,mofetil,mmf,5,n  170,csa  mmf,0,n  124,groups,younger,46,p  02,received,77%,p,Unnamed: 1296,01,regimen,containing,thiotepa,fludarabine,busulfan,84%,44%,48%,59%,15,46%,53%,05,refined,disease-free,rgrfs,33%,39%,36%,grade,ii-iv,gvhd,25%,18%,24%,37%,26%,02,start,hazard,ratio,hr,58,improved,62,administered,improves,pivotal,synucleinopathy,parkinson’s,pd,mediated,neurotoxic,alpha-synuclein,another,dementia,lewy,bodies,dlb,recent,aimed,estimate,plasma,profile,synucleinopathies,pdd,interferon-gamma,ifn-gamma,interleukin,il-4,il-6,il-10,tumor,necrosis,factor,alpha,tnf-alpha,monocyte,chemoattractant,protein-1,mcp-1,estimated,28,individuals,controls,luminex,array,assessed,mini–mental,state,mmse,elevated,p  005,p  0001,p  0026,p  0032,same,differences,pronounced,demetia,metastatic,non-small-cell,lung,cancer,mnsclc,experience,first-,second-line,options,required,arctic,phase,iii,open-label,durvalumab,tremelimumab,versus,care,soc,≥,third-line,comprised,independent,sub-studies,126,≥25%,tcs,expressing,programmed,ligand-1,10 mg/kg,every,weeks,q2w,b,469,tc,3 ,durvalumab ,20,mg/kg ,mg/kg,q4w,then,34,10,q12w,end,points,progression-free,pfs,descriptive,117,063,95%,confidence,interval,ci,042–093,38,22,071,049–104,115,87,080,061–105,p ,0109,077,059–101,0056,treatment-related,3/4,97%,444%,220%,364%,heavily,pretreated,clinically,meaningful,improvements,numerical,profiles,consistent,previous,registration,clinicaltrialsgov,identifier,nct02352948,because,intervals,ris,biochemistry,analytes,matched,population,defined,joined,global,values,rvs,coordinated,ifcc,committee,decision,c-ridl,harmonized,793,healthy,volunteers,recruited,saint-petersburg,moscow,yekaterinburg,variation,explored,regression,partitioning,sex,judged,deviation,anova,latent,abnormal,exclusion,lave,applied,influence,metabolic,inappropriate,sampling,computed,parametric,appreciable,between-city,partition,age-related,especially,females,trend,exaggerated,nutritional,closely,mass,bmi,increases,prominently,bmi  28 kg/m2,excluded,determining,age-specific,effective,lowering,established,biochemical,up-to-date,detailed,consideration,similar,participating,countries,adequate,transplacental,passage,maternal,thyroid,hormone,normal,fetal,growth,overt,hypothyroidism,hyperthyroidism,birthweight,knowledge,gaps,remain,subclinical,function,birthweight—both,third,trimester,pregnancy,examine,associations,individual-participant,meta-analysis,searched,medline,ovid,embase,web,science,cochrane,register,trials,google,scholar,inception,2019,prospective,issued,invitations,identify,authors,join,consortium,pregnancies,in-vitro,fertilisation,pre-existing,usage,miscarriages,stillbirths,sga,neonates,large,newborn,analysed,mixed-effects,models,adjusting,ethnicity,parity,birth,pre-registered,reviews,crd42016043496,2526,published,reports,36,cohorts,met,inclusion,criteria,agreed,participate,five,unpublished,datasets,added,giving,48 145,mother–child,pairs,exclusions,whom,1275,3·1%,stimulating,tsh,free,thyroxine,ft4,929,2·2%,isolated,hypothyroxinaemia,higher,euthyroidism,11·8%,vs,10·0%,adjusted,difference,2·43%,0·43,4·81,odds,1·24,1·04,1·48,p0·015,mean,−38,−61,−15,p0·0015,measurement,7·3%,−2·91,−4·49,−0·88,0·70,0·55,0·91,p0·0073,45,73,p0·0012,sd,6,–10,−2,p0·0030,estimates,women,peroxidase,negative,pinteraction0·10,–25,−17,p0·0001,interpretation,inverse,dose-response,within,advance,understanding,complex,relationships,prompt,careful,risks,benefits,levothyroxine,funding,netherlands,organization,grant,40116020,lorlatinib,third-generation,tyrosine-kinases,inhibitor,tki,targeting,alk/ros1,fusions,fda,approved,tki-pretreated,alk,nsclc,approval,ros1,pending,largest,real-world,harboring,rearrangements,123,enrolled,retrospectively,cut-off,1/1/2019,program,investigator,upon,recist,11,106,8,included,males,never-smokers,metastases,extracranial,ec,intracranial,ic,rates,rr,60,control,dcr,91,88,dot,239  16,mos,891  196,53,65,67,92,78,181  25,903  244,significantly,parameters,edema,48,hyperlipidemia,47,weight,gain,25,fatigue,1–2,shows,outstanding,ec/ic,89  19,supports,90  24,unprecedented,diabetes,mellitus,dysregulation,complications,suffer,diabetic,polyneuropathy,involves,presence,nerve,synthetic,arginine-rich,exendin-4,peptide,d,caused,neuropathy,induced,administering,streptozotocin,stz,10 μg/kg,byetta®,1 μg/kg,80,neuropathic,pain,tactile,allodynia,stz-treated,showed,unlike,naïve,histological,diameter,sciatic,fibers,smaller,ihc,myelin,mbp,resulted,myelinated,poly-arginine,peptides,promising,polyneuropathies,pattern,auditory,preterm,children,longitudinal,271,aged,old,divided,70,32–36,201,22–31,hearing,abr,assr,oae,audiometry,pure,tone,additionally,some,ct,gbj2,evaluations,assessments,3–4,times,year,under,2–3,over,infants,problems,examined,annual,snhl,ansd,257%,64,318%,occurrence,assessment,child,kinds,noted,loss,transformation,vice,versa,discussed,article,prematurely,born,tends,unstable,deteriorate,improve,before,weeks’,gestation,require,least,until,caution,advised,cochlear,implantation,32,introduction,single-arm,ascend-3,ceritinib,anaplastic,lymphoma,kinase,alki–naive,alk-rearranged,lines,chemotherapy,final,eligible,asymptomatic,neurologically,stable,oral,750,mg/day,fasted,investigator-assessed,orr,secondary,blinded,committee–assessed,investigator-,patient-reported,124,984%,antineoplastic,medications,250%,regimens,49,395%,baseline,cutoff,january,521,484–601,677%,588–759,166,110–232,513,427–553,grades,≥60%,all-causality,diarrhea,855%,nausea,782%,vomiting,718%,145%,event,discontinuation,health-related,quality,maintained,chemotherapy-pretreated,alki-naive,possibilities,angioprotection,osteonecrosis,given,bisphosphonates,experiment,27,injected,saline,zoledronic,acid,doses,sulodexide,constructed,teeth,extracted,velocity,linear,periodontal,area,tooth,high-frequency,doppler,ultrasound,vasoactive,substance,acetylcholine,3%,1min,structure,bony,tissues,head,microcirculation,mucous,membranes,greater,extent,tissue,causes,periosteal,includes,cellular,component,endothelium-dependent,vasodilation,membrane,vessels,reducing,restoration,reduces,subcortical,pathways,motor,spinal,cord,injury,sci,animal,descending,interlimb,lumbosacral,excitability,humans,ulnar,transcutaneous,condition-test,paradigm,connections,linking,cervical,segments,non-injured,n15,injured,n18,spinally,evoked,responses,semrs,7/7,volitional,leg,muscle,activation,6/11,rostral,innervation,entry,zones,modulation,pools,via,projections,exist,absence,significance,sub-clinical,spared,residual,rehabilitation,macrophages,regulation,morphogenetic,placenta,roles,unclear,placental,hofbauer,characterize,steps,production,intracellular,synthesis,secretion,compare,secretory,villous,placentas,9–12,38–40,determined,cytometry,secreted,quantified,cytometric,bead,patterns,il-1,il-8,tnfα,basal,stimulated,endotoxin,il-11,il-17a,il-17f,tgf-β,vegf,constitutive,did,respond,age-dependent,il-17,third-trimester,first-trimester,comparison,suggested,intraplacental,extraplacental,discussion,would,safe,assume,correspond,attenuated,supposedly,local,confined,mutations,glucocerebrosidase,gba,cause,gaucher,gd,lysosomal,storage,disorder,lsd,parkinson's,lysosome,functionality,plays,extracellular,vesicles,evs,content,terms,amounts,cargo,sequential,centrifugation,сryo-electron,microscopy,cryo-em,nanoparticle,tracking,nta,light,scattering,dls,exosomal,hsp70,tetrasponins,profiling,mass-spectrometry,shotgun,morphology,exosomes,derived,р00001,confirmed,mode,p  002,double,multilayer,enriched,surface,cd9,сd63,cd81,exosome-associated,proteomic,proteins,thus,striking,alteration,perform,postural,neuropsychiatric,tremor,et,phenotypes,combined,et-pd,169,10–20,111,advanced,25–30,hoehn,yahr,scale,26,non-motor,stabilometry,etpd,milder,parkinsonism,posture,walking,discovered,indexes,stabilometric,although,helpful,helps,expand,highlighted,autophagy,pathway,alp,genes,lrrk2,harbor,α-synuclein,encoded,snca,degraded,mainly,mutations/multiplications,chaperone,functions,pd-related,prkn,pink1,tmem175,smpd1,ctsd,ctsb,relationship,crucial,uncovering,long-awaited,neuroprotective,will,atypical,forms,elucidate,dynamical,complexity,impulse,sensory,neurons,emergence,antinociceptive,painful,stimulus,solve,problem,bifurcation,enabled,us,relations,nociceptive,neuron,shown,mechanism,suppression,ectopic,bursting,discharges,base,potassium,blocking,connected,entirely,modification,gating,nav18,sodium,channels,action,comenic,non-opioid,analgesic,anoceptin,explain,metoclopramide,widely,abortive,migraine,advantage,having,antiemetic,anti-cephalalgic,elucidated,taking,account,key,trigeminovascular,pathophysiology,investigate,neurogenic,dural,valid,electrophysiological,neurovascular,nociception,recordings,second-order,dura-sensitive,trigeminocervical,tcc,anaesthetised,cumulative,infusion,30 min,5 mg/kg,iv,step,n  8,dose-dependently,suppressed,firing,maximally,30%0–49%,medianq1-q3,4%0–30%,p  0001,contrast,separate,n  6,vehicle,p  005,unable,does,suppress,anti-migraine,neurophysiological,therapeutic,lipopolysaccharidein,affects,disturbances,disrupts,metabolism,immunoassay,biological,dynamics,simulation,checkpoints,predictor,tms/tes,eight-year,european,society,party,drinkers,daily,degranulation,release,influenza-sensitized,reversed,behalf,synucleinophaties,cancer☆,establishing,major,part,glass,real,exenatide,premature,of ceritinib,bisphosphonate,instability,overlapping,genetics,integral,protein-2,limp-2,scarb2,enzyme,rs6812193,rs68250047,genome-wide,rs8475,genotyped,604,fpd,539,history,spd,413,pd-gba,mutation,gba-carriers,cd45,linkage,disequilibrium,tt,variant,Unnamed: 93,202,0001,aao,gba-pd,padjusted,002,0003,0013,modified,modifier,do,buspirone,5-ht1ar,useful,abdominal,ibs,pain-related,5-ht1ars,located,tractus,solitarius,transmission,nts,urethane-anesthetized,types,responding,noxious,colorectal,distension,crd,inhibitory,sustained,10–40 mg kg−1,time-,dose-depended,crd-induced,inhibits,inverts,40,attenuates,crd-evoked,completely,blocked,intra-cerebroventricular,way100635,supraspinal,5-ht1a,dependents,anti-,pronociceptive,microrna,mirnas,artery,cad,expressions,myocardial,mirna-27а,mirna-133а,mirna-203,cross-sectional,100,subjects,609  10 years,men,right,atrial,mirna-27a,mirna,-133a,referred,elective,bypass,graft,surgery,cabg,scheduled,valve,correlation,syntax,r  0693,p  001,≥3,lesions,vessel,myocardium,23462  2951,18239  1962,relative,unit,reu,12753  1341,11135  1231,525  096,471  067,р  005,1141  385,482  182,842  243,435  123,14571  1573,4370  967,tree,multivessel,five-fold,10100,590,234–946,non-cad,corresponds,strongly,atherosclerosis,series,binuclear,pdii,carbene,complexes,synthesized,cis-pdcl2cnxyl2,benzo-13-thiazol-2-amines,2–6,structurally,regioisomers,interconvert,regioisomerization,diaminocarbene,first-order,intramolecularly,hammett,electron-withdrawing,substituents,benzothiazole,moiety,increasing,solvent,polarity,accelerate,strength,correlates,less,isomerization,interchange/dissociative,kinetic,spectrometric,rate-determining,breaking,carbon–nitrogen,bond,fragment,t2dm,ranks,top,worldwide,vascular,endothelial,endothelium-derived,imbalance,morphological,greatly,occurring,bed,wistar,fed,high-fat,diet,20 weeks,single,injection,20 mg/kg,glucose,tolerance,dose-dependent,contraction,third-order,mesenteric,arterioles,serotonin,phenylephrine,acetylcholine-dependent,relaxation,guanylate,cyclase,femoral,arteries,tendency,bioavailable,nitric,oxide,endothelin-1,conjunction,allow,novel,potent,few,reporting,non-small,n  5,n  26,none,n  4,prior,tyrosine,inhibitors,compassionate,dc,registered,15/35,33/35,94%,responsive,22/27,81%,27/27,218,approached,701,out,experienced,them,benefit,no-adverse-events,users,strikingly,remaining,237,105,reached,00001,comparisons,translocation,variants,statistical,v1,v3,regard,excellent,must,experiencing,bariatric,infarct,rat,no-reflow,phenomenon,sham-operated,ileal,transposition,roux-en-y,gastric,sleeve,gastrectomy,glucagon-like,peptide-1,insulin,subjected,ischemia-reperfusion,histochemical,determination,zone,stasis,wire,myography,reductions,compensation,normalized,provided,additional,alone,surgeries,t2dm-induced,enhanced,contractile,5-hydroxytryptamine,synthase,vasodilatation,infarct-limiting,augmented,contractility,beneficial,cardiovascular,investigates,event-related,oscillations,motion-onset,mor,sounds,moving,velocities,eeg,recorded,stationary,sound,motion,interaural,spectral,perturbation,ersp,inter-trial,itc,calculated,time-frequency,decomposition,signals,similarly,magnitude,cn1,cp2,components,delta-to-alpha,power,remained,highest,gradual,induce,non-coherent,conversely,abrupt,displacement,theta-alpha,consistency,generated,resetting,degree,considered,indicator,processing,currently,thought,full,glycogen,β-particle,spherical,shape,concentric,tiers,residues,glycogenin,about,42,nm,poorly,β-particles,hepatocytes,starved,situ,cytofluorometry,speed,schiff's,reagent,measurements,quickly,stained,labile,fraction,lf,represents,internal,sf,external,predicts,3rd,4th,bound,7th,8th,19%,tier,never,amount,particle,makes,obtain,particular,eculizumab,terminal,complement,anti-aquaporin-4,immunoglobulin,g-positive,aqp4,neuromyelitis,optica,spectrum,nmosd,prevent,asian,extension,ole,double-blind,intravenous,maintenance,1200 mg/2,completed,prespecified,subgroup,143,52,n  37,n  15,865%,concomitant,adjudicated,occurred,005,001–035,p  00002,952%,144,headache,nasopharyngitis,benefit–risk,identifiers,nct01892345,nct02003144,task,synchronization,intermittent,photic,arterial,hypertension,recurrence,instantaneous,frequencies,synchrosqueezed,wavelet,transform,manifested,photostimulation,bioelectric,shift,frequency,excitation,origin,sensitisation,mechanical,hyperalgesia,mechanotransduction,attack,unknown,ion,channel,piezo1,since,expressed,trigeminal,ganglion,took,relay,centre,directly,differently,yoda1,facilitated,contributed,intravital,dilation,meningeal,innervated,afferents,selective,mechanosensitive,favour,underlie,silica,silicon,dioxide,amorphous,varying,pore,volume,result,physicochemical,sorption,silanol,silicas,possibility,addition,aerosil,allows,composites,biologically,substances,biocompatibility,composite,380,spontaneous,photoinduced,cyto-,antiradical,interest,nanomaterial,applications,ability,inhibition,tumour,inactivation,immobilisation,drugs,theranostics,regions,carotid,organs,monitoring,o2,hypothesised,circulating,ventilation,modulate,hypoxic,ventilatory,cyclooxygenase,cox,nos,pretreatment,diclofenac,l-ng-nitro,arginine,methyl,ester,l-name,nonspecific,rebreathing,normoxia,hypoxia,nos-related,cross-talk,mediates,underlies,hla-haploidentical,post-transplantation-cyclophosphamide,pt-cy,feasible,procedure,malignancies,lacking,180,9,cr3,bm,64%,42-day,engraftment,889%,day-100,28%,219%,nrm,196%,419%,65%,188%,transplanted,multivariable,hr  219,p  04,older,13,hr  207,p  03,pbsc,hr  198,hr  313,option,profound,concerns,extreme,manifest,suicide,around,sourced,areas,internet,search,recourse,networks,literature,sept,nov,2020,official,websites,countries’,ministries,police,agencies,government-run,statistics,equivalents,translated,broadening,attempt,public,country,came,government,monthly,jan,july,searches,restricted,million,residents,pragmatic,reasons,relaxed,rule,interrupted,time-series,suicides,march,expected,april,high-income,upper-middle-income,whole-country,ten,ratios,rrs,cis,numbers,began,south,wales,australia,0·81,0·72–0·91,alberta,canada,0·80,0·68–0·93,british,columbia,0·76,0·66–0·87,chile,0·85,0·78–0·94,leipzig,0·49,0·32–0·74,0·94,0·91–0·96,zealand,0·79,0·68–0·91,korea,0·92–0·97,california,0·90,0·85–0·95,illinois,cook,county,0·67–0·93,texas,counties,0·82,0·68–0·98,ecuador,0·74,0·67–0·82,context,largely,unchanged,declined,pre-pandemic,vigilant,poised,situation,longer-term,economic,unfold,inject,pwid,stigma,utilization,help,cope,intersectional,adapted,coping,conduct,rct,‘stigma,treatment’,script,community-based,form,acceptance,commitment,civil,organizations,cso,delivering,harm,sessions,format,usual,psychological,flexibility,handle,stigma-related,expectations,emotions,experiences,satisfaction,scores,outside,formal,settings,confront,negativities,lives,originating,stigma's,barrier,encoding,gcase,commonly,parkinson,ambroxol,pharmacological,chaperones,fourteen,thirty,hexosylsphingosine,hexsph,dried,macrophage,spots,liquid,chromatography,coupled,tandem,spectrometry,lysosomes,confocal,cultured,monocytic,33-fold,35-fold,untreated,p  00001,cultivation,21-fold,16-fold,colocalization,marker,lamp2,modes,mutant,carrying,n370s,amino,substitution,ph,docking,simulations,position,minimal,energy,close,vicinity,residue,370,pbmc-derived,assessing,rationale,hemodialysis,hd,availability,accessibility,affordability,survey,clinicians,policy,makers,consumer,representatives,182,convened,nephrology,september 2018,analytical,160,88%,participated,country-specific,2984,iqr,805-5994,pmp,incident,980,815-1408,centers,12–99,3-4,hours,weekly,generally,low-income,home,32%,61% monitoring,small-solute,clearance,60% monitoring,mineral,51% monitoring,60%,initiation,dialysis,5%,arteriovenous,almost,education,suboptimal,procedures,uniform,copayments,income,23%,pay,75%,costs,4%,limitations,bias,desirability,collection,preventing,in-depth,variations,lowest,low-,lower-middle–income,refractory,induction,immunotherapy,dismal,salvage,hsct,10%,15%,cured,preclinical,bendamustine,ptb,prophylaxis,graft-versus-leukemia,gvl,antileukemic,nct02799147,140,mg/m2,single-agent,myelogenous,aml,≥5%,clonal,seven,stopping,documented,41%,blast,count,6%,sibling,mismatched,unrelated,93%,89%,63%,measurable,unusual,complication,crs,70%,frequent,fever,liver,tests,pancreatitis,skin,vasculitis,56%,enterocolitis,mucosa,disseminated,intravascular,coagulation,toxicity,hla-mismatched,p  0043,classic,p  031,severe,100-day,survivors,three-year,13%,event-free,29%,11%,statistically,p  3481,35%,0%,p  0157,augment,crs-associated,necessitates,routine,cannot,ameliorates,hla-matched,allografts,elucidation,scz,brain-derived,neurotropic,bdnf,measure,neuroplasticity,like,perception,first-episode,thirty-nine,43,mid-,except,middle,correlations,variables,mostly,alterations,magno-,parvocellular,functioning,highlights,biomarkers,5-year,bdfs,prostate,pencil,beam,scanning,pbs,proton,radiation,materials,2013,2016,284,modulated,impt,ultrahypofractionated,schedule,3625,gye,fractions,immediately,lost,279,prospectively,collected,565,34-875,645,401-857,prostate-specific,antigen,psa,635,μg/l,067-173,121,434%,low-risk,125,448%,favorable,33,118%,unfavorable,intermediate-risk,176%,neoadjuvant,hormonal,adjuvant,7-18,969%,917%,835%,terminology,v4,follows,gastrointestinal,22%,72%,036%,genitourinary,287%,61%,lymph,node,14%,recurrences,nine,deaths,comparable,fractionation,gi,gu,cajal-retzius,transient,elements,developing,cerebral,express,heavy-chain,neurofilaments,construction,mature,believed,feature,human’s,stain,smi-32,non-phosphorylated,horizontally,oriented,soma,bipolar,labeled,layer,cats,0–2,dii,well-developed,vertical,branches,coming,horizontal,visualized,location,suppose,carnivores,share,primates,developmental,corticogenesis,decades,semiconductor,lasers,successfully,rhinology,nasal,swell,nsb,barely,selection,970 nm,diode,thermometric,wavelength,continuous,contact,2 w,10 w,cattle,experiments,temperature,4 w,causing,thermal,damage,adjacent,breathing,hypertrophy,vasomotor,rhinitis,consisted,laser-turbinectomy,pathology,respiration,anterior,rhinomanometry,subgroups,t-criterion,nose,student's,t-test,subjectively,insufficiency,indicates,airflow,trace,amine-associated,taars,class,protein-coupled,biogenic,amines,products,decarboxylation,acids,taar2-taar9,olfactory,epithelium,sensing,innate,odors,taar5,limbic,projection,mouse,knockout,taar5-ko,beta-galactosidase,mapping,striatal,metabolites,gdnf,indicating,proliferation,subventricular,svz,subgranular,sgz,potentially,surrounding,ventricle,neurogenesis,doublecortin,dcx,proliferating,nuclear,pcna,observations,emotional,antagonists,exert,antidepressant,anxiolytic,opportunity,neurodegenerative,hemispheric,asymmetry,erps,low-frequency,oscillatory,hemispheres,stimuli,delayed,read,books,choice,passive,listening,indicated,trajectories,perceived,graphic,tablet,goal,find,lateralization,right-hemispheric,dominance,contralateral,neglect,interhemispheric,apparent,hemisphere,stronger,contralaterality,left,corresponding,delta-alpha,attention,consistently,interrelated,motion-related,single-trial,aquaporin-4,trigger,cascade,implicated,astrocyte,anti-aqp4,time-to-event,1200 mg/2 weeks,stable-dose,ist,permitted,rituximab,mitoxantrone,post,hoc,demographic,autoimmune,comorbidity,race,historical,annualized,disability,regardless,wide,tris-malonate,cf,plants,primarily,malonate,means,improving,crop,yield,physiological,plant,enough,netto,productivity,salad,tomatoes,spring,barley,wheat,seed,germination,vegetative,absorption,assimilation,capacity,roots,aerial,parts,moisture,entering,distributing,physiologically,organic,compounds,cyclic,catabolism,optimising,antioxidant,indicators,seedling,solutions,ccf  0001–01,mg·dm−3,peritoneal,practice,globe,n160,313,257,nephrologists,82%,non-nephrologist,physicians,7%,professionals,2%,administrators/policy,makers/civil,servants,85%,n156,responded,questions,381,156,africa,20/41,15/22,69%,modality,for≤10%,newly,1%,out-of-pocket,expenses,incurred,asia,average,exchange,volumes,exchanges,equivalent,automated,explanations,underpinning,granular,inter-,intraregional,disparities,greatest,dydrogesterone,management,endometriosis-related,pelvic,twenty,gynecology,federation,fifty,endometriosis,dysmenorrhea,mg,5th,25th,menstrual,cycle,cyclical,continuously,11-point,rating,marked,–33,–30,analgesics,well-being,quality-of-life,a favorable,reactions,led,nct03690765,los,regímenes,de,tratamiento,didrogesterona,cíclicos,y,continuos,prolongados,son,efectivos,para,reducir,el,dolor,pélvico,crónico,en,mujeres,con,resultados,del,estudio,orchidea,objetivo,comparar,la,efectividad,dos,diferentes,manejo,relacionado,diseño,cohortes,prospectivo,observacional,durante,seis,meses,entorno,veinte,clínicas,ginecológicas,federación,rusa,pacientes,trescientas,cincuenta,entre,años,edad,o,sin,dismenorrea,intervenciónes,ó,veces,al,día,bien,días,ciclo,menestrual,régimen,cíclico,prolongado,ininterrumpido,continuo,todas,las,se,limitó,recogida,datos,medidas,resultado,principales,intensidad,una,escala,puntuación,numérica,puntos,tras,observó,marcada,reducción,tanto,como,cambio,nivel,medio,desviación,estándar,-33,-30,respectivamente,diferencia,significativa,ambos,grupos,experimentaron,mejoras,significativas,número,que,requirieron,analgésicos,severidad,bienestar,parámetros,calidad,vida,relacionados,salud,confirmó,un,perfil,seguridad,informó,reacciones,adversas,severas,medicación,conclusiónes,demostraron,pronunciada,resultaron,marcadas,todos,estudiados,strategies,needed,optimise,surgical,resection,early-stage,atezolizumab,best,supportive,platinum-based,impower010,randomised,multicentre,done,227,sites,resected,ib,≥4,cm,iiia,union,internationale,contre,le,american,joint,staging,edition,permuted-block,block,1200,cycles,regular,scans,endpoint,hierarchically,ii–iiia,whose,sp263,finally,intention-to-treat,itt,ib–iiia,nct02486718,2015,1280,1269,1005,randomisation,n507,n498,495,32·2,27·4–38·3,0·66,0·50–0·88,p0·0039,0·64–0·96,p0·020,0·67–0·99,p0·040,atezolizumab-related,offers,f,hoffmann-la,roche,genentech,buspirone-dependent,diaminocarbenepdii,region-specific,opposite,carcinomas,cytochemical,anti-aquaporin-igg-positive,estimation,nanocomposite,mediate,unmanipulated,post-transplant,trends,restores,patient-derived,dose-ranging,cancer-5-year,labeling,feline,midbrain,periaqueductal,gray,pag,gut,inflammation-triggered,pag-executed,visceral,c-fos,immunohistochemistry,microelectrode,recording,colitis-induced,outflow,caudal,ventrolateral,medulla,cvlm,inflamed,diminished,columns,nonstimulated,subdivisions,colitis-elicited,crd-excited,unresponsive,weakened,crd-inhibited,units,colonic,electrostimulation,colitis,ascending,injury-associated,postinflammatory,stigmatized,face,accessing,art,natural,165,art-naïve,enrollment,andgeneralized,estimating,equations,12-,24-month,visits,logistic,gender,cd4,30-day,depressive,q1,q3,37,30%,350,31%,initiated,85,468,1361,yearly,057,-136,022,27/47,574%,initiate,aor,099,95%ci,094–104,101,096–105,unlikely,barriers,eg,promoting,equal,substance-use,success,stigma-reduction,prevalent,hepatitis,c,hcv,co-infection,alcohol's,harmful,identifying,continued,unhealthy,situational,motivational,hiv/hcv,co-infected,guided,semi-structured,interviews,facilitators,abstaining,thematic,awareness,episodic,situations,motive,triggered,stressful,work-,family-related,conflicts,friends,endorsed,motives,motivated,stop,cited,abstain,opportunities,awareness-raising,training,persons,relatives,degrees,lockdown,thoroughly,comet-g,pertaining,material,gathered,online,questionnaire,55589,6485%,3580 ,3405%,34901329,110%,31641315,anxiety,stai,depression,ces-d,suicidality,rass,distress,probable,calculation,factorial,backwards,stepwise,two-thirds,172,psychiatric,688,though,suggestions,concerning,proactive,protect,vulnerable,ce,cuso4,2-hydroxypropyl-β-cyclodextrin,additives,electrolyte,ph 43,lactic,"""healthy""",non-alcoholic,fatty,hepg2,vitro,oleate,palmitate,simulate,excessive,triglyceride,viability,order,check,culture,medium,evaluating,repeatability,intermediate,precision,peak,migration,accuracy,trueness,quantitation,proved,sensitive,reliable,accurate,concentrations,arg,ala,glu,gln,myeloperoxidase,mpo,oxidant-producing,neutrophils,prime,immunothrombosis,native,homodimer,consisting,identical,protomers,monomer,disulfide,foci,dimer,beside,oxidants,ultimately,ceruloplasmin,cp,monomeric,hemi-mpo,treating,dimeric,reductive,alkylation,hocl,molar,1100,mpo-hocl,surface-enhanced,raman,sers,spectroscopy,peaks,510,526 cm−1,corresponded,recognizable,sers-spectra,absent,intense,spectra,cleavage,lesser,platelets,agonist-induced,platelet-neutrophil,aggregate,consequently,decreases,thrombosis,1950′s,physicist,m,bongard,silent,dimensions,colour,vision,derive,colour-matching,whole,organisms,individual,1956,colleague,s,smirnov,extra-foveal,tetrachromatic,silent-substitution,called,‘replacement,colorimetry’,steady,trichromatic,matches,transients,visible,match,replaced,primaries,ones,chromatic,adaptation,fourth,rods,long,discovery,intrinsically,photosensitive,fiftieth,anniversary,bongard’s,grievous,translation,smirnov’s,tetrachromacy,commentary,give,details,apparatus,briefly,reception,west,claims,analogy,parafovea,‘weak,tetrachromacy’,heterozygotes,anomalous,bpd,cognition,controversies,performance,executive,memory,medication-naive,olanzapine,forty-one,unmedicated,drug-naive,flanker,stroop,corsi-block,bayesian,run,considering,maximum,robustness,avoid,predict,worse,tasks,dosage,ie,pro-cognitive,carefully,interpreted,expect,helping,researchers,picture,changing,vary,timely,pandemic's,globally,public-sector,countries/areas-within-countries,searching,academic,contacting,custodians,necessary,sent,request,22nd,june,2021,stopped,collecting,31st,october,sex-,age-,sex-by-age,country/area-within-country,10-15,meta-regression,lower-middle-income,areas-within-the-country,greater-than-expected,lower-than-expected,certain,stood,explained,stringency,national,fared,age-based,minority,upward,place,alert,alk-positive,histiocytosis,subtype,histiocytic,neoplasm,2008,multisystemic,involving,entity,subsequently,occupy,wider,clinicopathologic,kif5b-alk,date,phenotypic,originally,1a,6/39,1b,10/39,single-system,23/39,nineteen,entire,neurologic,histology,xanthogranuloma,one-third,displayed,densely,monomorphic,appearance,lipidized,histiocytes,spindled,epithelioid,neoplastic,conferred,strong,phosphorylated,signal-regulated,mapk,cltc-alk,tpm3-alk,tfg-alk,eml4-alk,dctn1-alk,durable,11/11,presents,landscape,guidance,emerging,practically,comprehensive,dedicated,differentiate,cluster,clustering,ftms,adl,moca,beka,electromyographic,uric,mda,psychoemotional,adaptive,homogeneous,clusters,revealing,electrodes,basement,vertebral,spinous,stably,fixed,selectivity,transvertebral,ts,forward,stepping,cat's,hindlimbs,epidural,es,electrode,placed,vl3–vl6,vertebrae,decerebrated,l5–l7,kinematic,musculus,iliopsoas,tibialis,ta,gastrocnemius,lateralis,gl,vl3–vl4,capable,bipedal,vl5,vl6,well-coordinated,intra-,coordination,ts-induced,vl3,vertebra,lock,integer,ts-evoked,site,vl4–vl5,vl5–vl6,hypotheses,generators,lumbar,placement,surgically,easier,site-specific,neuromodulation,sensorimotor,investigating,hormones,menopause,detrimental,woman's,mood,challenge,peri-,postmenopausal,methodological,scoping,electronic,databases,pubmed,scopus,wos,publications,menopausal,subject,records,full-text,1986,methodologies,studies16,investigations,addressed,domains,implications,appropriate,screen,woman,suffers,strengths,Unnamed: 1257,reproductive,topic,clearly,warranted,appears,bidirectional,dysfunctions,attitudes,partners,sleep,multiparity,azam,rahmani,elahe,afsharnia,julia,fedotova,shirin,shahbazi,arezoo,fallahi,leila,allahqoli,reza,ghaneipoklgheshlagh,sarah,abboud,ibrahim,alkatout,j,med,2022191098–1115,curative,wiskott-aldrich,respect,donors,predicting,poorer,197,undergoing,2006,inborn,errors,iewp,n,103,treosulfan,94,post-hsct,449,176,alive,resulting,887%,gvhd-free,817%,busulfan-,treosulfan-based,donor/matched,donor/mismatched,2006-2013,2014-2017,extensive/moderate/severe,66%,mixed,chimerism,frequently,unconditioned,boost,lymphocyte,splenectomy,≥5,tetrahydrobiopterin,bh4,deficiency,precisely,93,folate,cobalamin,b12,homocysteine,c-reactive,crp,glutathione,gsh,serumpatients,psychopathological,p  0054,p  0012,moderately,ρ  043,p  00029,p  00020,inversely,ρ  −054,p  000015,biotype,hyperhomocysteinemia,noninvasive,understand,states,symptom,low-level,csf,fifty-six,hcs,age  3104,age  3284,lithium,age  3280,differed,discrimination,exception,mediation,aid,state-,trait-like,underscores,remediation,pdt,hpv,session,multi-course,depended,treatments,probability,kaplan,meier,estimator,elimiantion,three-month,r2  071,90%,08,ci95%,053–1,mild,357%,286%,leucocyte,demonstrates,cc,five-year,completing,multi-treatment,invasive,achieve,non-interruptive,rall-2009,fulfilled,auto-hematopoietic,t-cell,reliably,dfs,non-randomized,auto-hsct,cht,appreciate,rall-2006,rall-2016,achieved,brought,randomization,informed,consent,267,ph-negative,dec,apr,2022,74%,5y,68%,precursor,etp-all,poor,pr,52%,1st,pts,44,refused,censored,refuse,arms,went,allo-hsct,mixed-lineage,mll,niimegem,mrd,persistence,conditioned,iomustine,etoposide,cytarabine,melphalan,ceam,transplant-related,landmark,didn't,78%,mrd-,86%,40%,auto-hcst,etp-phenotype,prognostic,high-dose,consolidation,medieval,yoga,texts,claim,special,exercise,muscles,wall,agnisara,digestive,superior,volumetric,sma,performing,carried,sexes,systolic,diastolic,contrasts,splanchnic,physical,properly,supply,successful,uncomplicated,hypertensive,definitions,conflicting,pre-eclampsia,database,thyroid-stimulating,tpo,individually,multifetal,prospero,crd42019128585,1539,46 528,pregnant,39 826,85·6%,sufficient,classified,3·2%,933,2·3%,619,1·6%,337,0·8%,2·1%,3·6%,1·53,1·09–2·15,positivity,u-shaped,quantify,adding,defining,interventional,arkansas,biosciences,institute,methotrexate,mtx,msd,allo-hct,recently,registry-based,118,1202,csa/mtx,matched-pair,411%,213%,p  039,252%,254%,p  90,426%,p  84,544%,7432%,p  052,706%,797%,p  15,381%,525%,p  49,conventional,©,elsevier,inc,lifetime,illicit,russia–a,self-identified,cu2,ions,structure-biological,9-15,highlighting,decerebrate,cat,ebmt,all-056,intensification,autologous,non-myeloablative,can't,non-intensive,multicentral,rall,yogic
0,ВСТРЕТИЛОСЬ РАЗ в файле 2020.txt,32,5.0,242,1.0,2.0,24,4.0,6,388,5,369,6,319,1.0,4,8,5,10,11,2.0,37,14,4.0,3,3.0,3.0,3.0,4.0,9.0,40,4,33,3.0,11,14,4.0,3,9,3.0,86,2,2.0,2.0,3,4,2.0,2.0,4,41,2,11,1.0,1.0,1.0,1.0,1.0,4.0,1.0,37,1.0,4.0,6.0,2.0,2.0,28,22,1.0,3.0,20,7,84,1.0,1,1.0,8.0,31,1.0,14,2.0,2.0,13,1.0,1.0,1.0,2,3.0,2.0,76,10,8,1.0,1.0,1.0,9.0,1.0,2,5,2.0,1.0,6,2.0,1.0,2,7.0,1,1.0,1.0,1.0,1.0,2.0,3,48,7,8,5,1.0,2.0,3.0,12,15,1.0,1.0,2.0,2.0,7,8.0,1.0,2.0,1.0,2.0,6,129,2.0,4.0,15,3.0,1.0,7,4,1.0,5,2.0,4.0,1,3,32,24,16,5,1.0,7,1.0,1.0,5,2.0,5,21,85,1.0,2.0,4.0,1.0,1.0,10.0,2.0,11,5.0,7,1.0,2.0,2.0,1.0,8,1.0,7.0,1.0,3.0,1.0,1.0,11,3,18,4,27.0,2.0,3.0,2.0,3.0,2,1.0,141,1.0,1.0,11,13,1.0,6.0,1.0,1.0,6,1.0,7,1.0,1.0,1.0,1.0,1.0,1.0,4.0,4,1.0,2.0,2.0,1.0,2.0,5,5,8,1,1.0,15,2.0,2.0,1.0,8,1.0,1.0,3,3,1.0,1.0,25,2,2,1.0,1.0,1.0,3,6.0,18,1,3.0,5,1.0,1,3.0,2.0,1.0,1.0,1.0,4.0,2.0,13,5,1,1.0,5,8,2.0,5,4,2.0,2.0,2,1.0,1.0,8,2.0,2.0,1.0,2.0,4,3.0,3,1.0,1.0,2.0,1.0,1,2.0,8,6,2.0,22,10,1.0,11,3.0,1.0,10,1.0,1,2,1.0,4,1.0,4,3.0,1.0,1.0,2.0,1.0,1.0,1.0,2.0,1.0,7.0,7,6.0,1.0,1.0,1.0,1.0,10,11,1.0,14,2,3.0,5.0,1.0,1.0,8,1.0,1.0,16,1.0,3,2.0,6,6,1.0,2.0,2.0,5,1.0,2.0,1.0,1.0,1.0,1.0,1.0,6,4.0,2.0,1.0,1.0,2.0,8.0,4.0,1.0,2.0,6,2.0,2,4.0,3.0,2,1.0,2,1.0,1.0,4,1.0,3.0,3.0,1.0,3.0,10,1.0,1.0,2,2.0,1.0,1,3,1.0,1.0,1.0,1.0,1.0,6.0,1.0,7,1,10,4.0,3.0,1.0,3,3.0,1.0,18,1.0,1.0,2.0,6,3,2.0,1.0,1.0,11,1.0,2.0,1.0,1.0,17,1.0,1,1.0,1.0,1.0,2.0,1,4.0,1.0,4,1.0,1.0,2.0,3.0,1.0,7,5,2.0,2,1.0,1.0,12,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,4.0,1,2,1.0,1.0,5,1.0,1.0,1.0,1.0,4,2.0,1.0,9,1.0,1.0,3.0,1.0,1.0,1,4,2.0,1.0,2.0,3.0,1.0,2.0,1.0,1.0,1.0,1.0,7.0,3,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,8,2.0,1.0,1.0,1,1,1.0,6.0,1.0,7,1.0,3,2.0,3,2.0,1,1.0,1.0,4,6,1.0,7.0,2.0,1.0,1,3.0,1.0,3.0,4,1,14,5,6.0,3,5.0,7,2.0,3,72,2.0,3,3.0,22,2.0,8,2.0,7,1.0,1.0,2.0,1.0,2.0,1,2,1.0,2.0,5.0,2.0,1.0,2.0,3.0,4.0,7,3.0,3,14,1.0,1.0,1.0,7.0,8,8.0,1.0,1.0,1.0,5,1.0,1.0,2.0,1.0,2,2.0,2.0,14,4,1.0,1.0,5,33,11,1.0,1.0,1.0,1.0,14,3,1.0,1.0,4.0,4,2.0,1.0,1.0,9.0,1.0,6,1.0,1,3.0,1,5,12,6,1.0,1.0,1.0,9,10.0,3.0,7.0,1.0,1.0,1.0,4.0,2.0,1.0,4,1.0,2.0,1.0,1.0,1.0,1.0,1.0,3,1,3.0,3,4,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,4,1.0,1.0,1,3,3,1.0,1.0,2,3.0,3.0,6,4,1.0,3.0,1.0,1.0,3,7.0,4.0,3,1.0,8,1.0,2.0,4.0,2.0,1.0,2,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2,1,2.0,2.0,2.0,1.0,1.0,1.0,4,1.0,2.0,5.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1,2,1.0,1.0,1.0,1.0,1.0,1.0,5,3,10,1.0,1,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,7,6,2,1.0,1.0,1,1.0,1.0,1.0,2,2,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1,2,9,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,3.0,5,2.0,2,8,4.0,5.0,2.0,2,3.0,5.0,5.0,7,9.0,3.0,4.0,1.0,6,1,1.0,1.0,1.0,1,5,6,2.0,2.0,23,1.0,2.0,2.0,1.0,4.0,4.0,1.0,1.0,1.0,3,5.0,2.0,1.0,1.0,1.0,20,1.0,1.0,2.0,3,1,5,12,1.0,1,2.0,3,1,1.0,2.0,5,4.0,4.0,2.0,2.0,3.0,2.0,5.0,3.0,1.0,1.0,2.0,1,3,2,1.0,5,8,2.0,1.0,1.0,4.0,7.0,1.0,2.0,3.0,2.0,1.0,2,2,1.0,3.0,1.0,4,1.0,2.0,1.0,1.0,5.0,1.0,1.0,1.0,1.0,1.0,2.0,4.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,3.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,5,2,6,1,5,1.0,4,3,1.0,2.0,1.0,2.0,1.0,1.0,1.0,4.0,2.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,3.0,1.0,6,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,4.0,5.0,2.0,1.0,2.0,2.0,4.0,2.0,1.0,1.0,1.0,1.0,1.0,3,1.0,1.0,6,1.0,1.0,1.0,2.0,3,1.0,1,1.0,4.0,1.0,1.0,1,2,1,2,7,2.0,1.0,2.0,2,5,2.0,6,1.0,1,4.0,1.0,1.0,1,2,1.0,1.0,2.0,2,2.0,3,2.0,1,2.0,1.0,12,3,3,3.0,3.0,4,4,8.0,1.0,1.0,4,1,1.0,19,3,1.0,2,2.0,3,1.0,3.0,11,2.0,8.0,13,2,1.0,2.0,1.0,1.0,3.0,2.0,3,1.0,1.0,1.0,8,1.0,1.0,2.0,6.0,2.0,2.0,1.0,1.0,5.0,2.0,2.0,5,4.0,1.0,1.0,1,2,3.0,1,2.0,1.0,2,5,1.0,4,1.0,2,1.0,1.0,4,5.0,4.0,8.0,1.0,1.0,1.0,3.0,1,4.0,8.0,4,1,2,4.0,4.0,2.0,2.0,2.0,3.0,4,8.0,2,2.0,1,1.0,3.0,1,2,1.0,1.0,3.0,1.0,1.0,4,1.0,1.0,6,4.0,4,2.0,1.0,1.0,9,3.0,1.0,2,1.0,3.0,1.0,1.0,1.0,2.0,2,7,1,1.0,2.0,3,1.0,3.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,4,1.0,15,1.0,3,10,1.0,2.0,1.0,1.0,1.0,1.0,1.0,8,3,4.0,5.0,2.0,2.0,3.0,7.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1,5,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,4,2,1.0,2.0,1,1.0,1.0,1.0,2.0,1.0,3.0,1.0,1.0,4.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,3.0,12,1.0,2,4,1.0,1.0,1.0,15,1.0,1.0,1.0,10.0,1.0,1.0,6.0,1.0,1.0,4.0,1.0,3,1.0,1.0,4,1,1.0,4,2.0,2.0,1.0,3.0,1.0,7.0,1.0,1.0,2.0,1.0,1.0,3.0,1.0,1,1.0,1.0,1.0,1.0,1.0,1.0,1.0,4,1.0,2.0,1.0,2.0,1.0,1.0,5.0,1.0,1.0,2.0,3,1,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,7.0,1.0,1.0,1,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1,4.0,1.0,1.0,1.0,3,1.0,1.0,1,1.0,3.0,1.0,1,1.0,3.0,3.0,1.0,3.0,1.0,1,1.0,1.0,1.0,1.0,1.0,1.0,1.0,5,1.0,2.0,1.0,1.0,8,1.0,1.0,3.0,5,1.0,9.0,5.0,4.0,1,1.0,1.0,1,1,1.0,1,1.0,1.0,5,1.0,1.0,1.0,1.0,1.0,3.0,1.0,2.0,2.0,4,1,2,4,1.0,1.0,1.0,2.0,2.0,2,2.0,4,6.0,1.0,2,3.0,2.0,2.0,1.0,2.0,2.0,29.0,2.0,1.0,1.0,1,7.0,1.0,1.0,6.0,2,2,3.0,13.0,3.0,3.0,6.0,1.0,2.0,1.0,2.0,4.0,4.0,2.0,1.0,2,1.0,3.0,1.0,1.0,1.0,2.0,1,1,2.0,8,1.0,2.0,7,1.0,1,1.0,1.0,2.0,3,1.0,1.0,2,2,3.0,1.0,2.0,2.0,2.0,1,3.0,1.0,1.0,1.0,1.0,2.0,3.0,3.0,1.0,1.0,11.0,9.0,8,1,12.0,1.0,2.0,1,3,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1,14.0,3.0,4.0,1.0,3.0,1.0,5.0,1.0,1.0,4.0,2.0,2,3.0,3,1.0,4.0,3.0,2.0,8.0,1.0,1.0,1.0,8,2.0,2.0,8,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,1.0,2.0,2,5,1.0,1.0,1.0,1.0,3.0,4.0,7.0,2.0,7.0,2,4,2.0,1.0,3.0,4.0,6.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1,2.0,2,1.0,1.0,1.0,2.0,1.0,2.0,1.0,3,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1,3.0,2.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1,1.0,1.0,2.0,1.0,1.0,3.0,2,1.0,1.0,2,1.0,2.0,1,1.0,1,2,1.0,1.0,2.0,1,1.0,2,1,1.0,1.0,11.0,11.0,2.0,6.0,3.0,1.0,1.0,4.0,1.0,12.0,1.0,1.0,2,4.0,10,1.0,3.0,3.0,6.0,1,1.0,3.0,2.0,1,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1,4,1.0,1.0,1,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,2.0,1,1.0,1.0,1.0,3.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1,2.0,1.0,3.0,1.0,1,2,1.0,2,1,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1,1.0,1.0,1.0,4.0,1,1.0,4.0,1.0,1.0,5.0,3.0,7,2.0,1.0,2,2.0,2.0,7.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,5,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,2,1.0,1,1.0,1.0,1.0,1.0,1,1.0,1.0,2,1.0,4.0,3,1.0,1.0,1.0,1,1.0,1.0,1,1.0,1.0,1.0,1.0,6.0,1.0,1.0,2,1.0,1.0,3.0,1.0,1.0,1.0,1.0,7,9.0,1.0,5.0,1.0,1.0,1.0,1.0,1,2.0,4,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,2,2.0,2.0,4.0,1.0,2.0,2.0,2.0,2,2,1.0,3,2.0,1.0,1.0,3.0,1.0,4.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,3,3,1.0,1.0,1.0,1.0,1.0,1.0,1,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,4.0,2.0,1.0,2.0,1.0,5.0,1.0,1.0,3,7.0,1.0,2.0,1.0,5.0,5.0,1,2.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,2.0,2,3.0,3.0,2.0,3,1.0,3.0,1.0,2,3.0,2.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1,4.0,3.0,17.0,1.0,1.0,2,1.0,2.0,1.0,1.0,1.0,1.0,8.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,2,1.0,1.0,1.0,1.0,2.0,4,4,3.0,2.0,1,3.0,1.0,1,1.0,2.0,3.0,1.0,1.0,1.0,1.0,2,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,3.0,1.0,1.0,1.0,1,3,1.0,5.0,1.0,4,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,4.0,1.0,1.0,1,1.0,2.0,3.0,1,2.0,1,1.0,1.0,1,1.0,1.0,1.0,1.0,2.0,3.0,1,2.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1,1.0,1.0,2,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,3.0,3.0,1.0,1.0,1,1.0,3.0,5.0,6,1.0,3.0,1.0,1.0,2.0,1.0,1.0,1.0,1,1.0,1.0,1.0,1.0,1.0,2,1.0,1.0,1.0,1,3.0,2.0,1.0,4.0,4.0,3.0,1.0,1,5.0,1,1.0,1.0,2.0,1.0,1.0,3.0,1.0,1.0,1,1.0,1,1.0,3.0,7,6,4.0,3.0,7.0,1,2.0,4.0,4.0,2.0,1.0,3.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2,3,2.0,1.0,3.0,2.0,2.0,6,1.0,1.0,1.0,1.0,1.0,1,1.0,2,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,11.0,1.0,2.0,1.0,5.0,1,8.0,1.0,1.0,2.0,8.0,2.0,1.0,4.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,6,1.0,2.0,2.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,2,1,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1,1.0,2.0,1.0,2.0,1,2.0,6.0,4.0,1.0,1,1.0,4.0,1.0,1.0,1.0,2,2.0,5.0,1.0,1,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,2.0,1,1.0,2.0,3.0,2.0,1.0,2.0,1.0,1.0,2,4.0,1.0,1.0,1,1.0,1.0,1.0,1.0,1.0,1,1.0,1.0,1.0,1.0,1.0,3.0,2,1.0,1.0,1,3.0,2.0,2.0,8.0,1.0,1,5.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,4.0,1.0,2.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,3.0,2,8.0,5.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1,1.0,1.0,1.0,1.0,3.0,1.0,1,1.0,3.0,3.0,1.0,2.0,6,3.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1,6.0,3.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1,4.0,1.0,1.0,3.0,1.0,1.0,8.0,1,1.0,4.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1,5.0,1.0,1,2.0,3.0,1.0,1,1.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,2,2.0,1.0,2.0,2,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1,1.0,2.0,1.0,1.0,1.0,1,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,ВСТРЕТИЛОСЬ РАЗ в файле 2021.txt,33,1.0,280,1.0,,28,,1,443,3,360,3,295,,2,8,3,4,15,,46,8,,3,,,,6.0,10.0,35,3,33,,5,5,1.0,2,8,,71,4,,,7,1,,,4,37,1,13,,,,,,1.0,,45,,2.0,4.0,,,24,13,,,11,6,101,1.0,2,,,31,,25,,,14,3.0,1.0,1.0,6,,4.0,70,13,6,,,,2.0,,1,6,,,11,,,2,3.0,8,,,1.0,,1.0,1,36,9,12,3,,,,9,17,2.0,,,,2,4.0,,,,4.0,3,131,,,10,,,14,2,1.0,8,,1.0,3,1,30,19,20,5,1.0,11,,,1,3.0,3,32,92,,,,,,5.0,,9,,7,,,,,3,,8.0,1.0,,,,12,3,11,1,,,,,2.0,3,,142,,2.0,2,9,,,,8.0,6,,9,,1.0,,,,3.0,3.0,9,8.0,,,,,5,6,7,2,,20,,,,8,,,5,2,,,23,2,2,,4.0,,5,,23,3,1.0,2,,2,,,,,,,1.0,9,1,4,,8,13,,1,8,,,1,,,4,,,,,4,4.0,1,,,,,4,1.0,21,4,,39,7,,9,,1.0,9,,3,6,,1,,1,7.0,,,,,,2.0,,,,4,,,,,1.0,8,8,,19,7,1.0,,,,9,,,9,,1,1.0,5,5,,,,5,,,,,,,,1,,,,,,,,1.0,2.0,6,,1,,,1,,2,,,12,,,,,,16,,,3,,,3,2,,,,,,,,8,1,4,,,,2,1.0,,13,,1.0,,2,1,,,1.0,6,1.0,,,,9,1.0,1,,,,,1,4.0,,5,,1.0,,6.0,1.0,4,6,1.0,4,1.0,1.0,8,1.0,1.0,2.0,1.0,,,4.0,,1.0,,,2,2,2.0,,9,,4.0,,,24,1.0,,1,1.0,2.0,,,1.0,1,2,1.0,7.0,,7.0,,,,,3.0,3.0,,8,,1.0,,,,,,,4.0,,7,1.0,,1.0,1,1,1.0,1.0,,13,1.0,2,,1,,2,,,4,4,,9.0,,,4,3.0,1.0,,4,2,8,3,,4,5.0,3,,2,115,,1,,16,,2,,3,1.0,,1.0,5.0,1.0,1,1,,,3.0,,,,,,5,,1,16,,,2.0,,4,1.0,,,,7,,,,,1,1.0,,12,5,,,1,7,9,,,,1.0,11,3,,,,5,1.0,,,,,8,,1,,1,7,5,8,,,,2,,,3.0,,1.0,,,,1.0,1,,1.0,,,,,,4,4,,3,10,,,,,1.0,,,,,,1,,,3,3,10,,,3,2.0,,2,1,,,,,1,6.0,,1,,20,2.0,,,,,3,,,,1.0,,,,,1,1,,,,,1.0,,3,,1.0,1.0,,,,,,,,1,4,,,,,,,8,10,6,,6,,,,,,,,,,8,5,3,,,1,,,,3,1,,,,,,,1.0,,,,,,4,1,6,1.0,,,,,,,,,,,,,3.0,3,1.0,1,1,,,,2,,,,5,2.0,,,,7,1,,,,2,6,2,2.0,,7,,1.0,4.0,,,,,,,3,1.0,1.0,,,,12,,,1.0,1,1,3,6,1.0,1,2.0,3,1,,1.0,6,,,,,,,,2.0,,1.0,,2,2,1,2.0,9,6,2.0,,,2.0,,,,,,,3,3,,,,8,,1.0,,,,,,,1.0,5.0,,1.0,,,,,,3.0,,,,,,1.0,,,,,,,,,,,,,,1.0,7.0,,,,,4,3,4,5,2,,1,1,,,1.0,,,,,,,,,,2.0,,,1.0,,,,,1.0,3,,,,,,,,,,2.0,,,2.0,,,,,,,,,,,10,1.0,,13,2.0,,1.0,9.0,2,,1,,,1.0,1.0,3,1,1,1,4,1.0,,,3,7,,5,,5,2.0,,,4,4,,,,3,5.0,2,,1,1.0,,13,3,6,,4.0,2,2,,,,2,2,,13,2,,12,2.0,4,1.0,,8,,,3,3,,,1.0,1.0,,,7,,,,3,1.0,5.0,,,,5.0,,1.0,7.0,,,2,,,,2,1,,1,,,7,2,,3,,3,,1.0,7,,,,,5.0,1.0,,5,5.0,,3,4,2,,,,,,,1,3.0,2,,1,1.0,,1,1,,,,,,3,,,6,2.0,10,3.0,,1.0,16,,1.0,6,1.0,,,,,1.0,3,5,3,4.0,4.0,3,,8.0,,,,,,,1.0,7,,12,,4,18,,,,,,,,1,5,,2.0,,,,5.0,,,,,,,1.0,2,3,1.0,6.0,,,,,,,2,4,1.0,,4,,,,1.0,,1.0,,,,,1.0,,,,,,,9,1.0,2,1,,,,13,,,,,,,,,,,2.0,2,,,1,1,,3,,,,3.0,,,,3.0,,2.0,,,,3,,,,,,,,3,,,1.0,,,,,,1.0,,2,1,,,2.0,,2.0,,,,1.0,,,,,1,,,3.0,5.0,,,,,2,,,1.0,,1,,,1,,,2.0,3,,,,1.0,2.0,,4,2.0,,,,1.0,1.0,2.0,8,,,1.0,,8,,,,11,,2.0,,,3,1.0,,1,1,,4,1.0,1.0,1,3.0,,,,5.0,,,,1.0,12,2,6,4,2.0,1.0,2.0,2.0,,1,2.0,3,2.0,,2,1.0,1.0,,,,,27.0,2.0,,,2,,,1.0,,2,4,,1.0,3.0,,,,,,,,,1.0,1.0,4,,,,,,,5,1,3.0,6,,,1,,2,,1.0,1.0,1,,,4,4,2.0,,,2.0,6.0,11,,1.0,,,,1.0,,18.0,,5.0,,,9,15,,,,2,3,,,,,,,,,3,3.0,,,,,,,3.0,,1.0,,1,,4,,,,,3.0,2.0,,,9,2.0,2.0,7,,,7.0,,,1.0,,,,,,,,,,,1.0,,,1.0,,,2.0,,2.0,1.0,1.0,1,3,3.0,3.0,,,,,,,,2,14,2.0,,2.0,,,,,1.0,1.0,,,,2,,1,,,,,1.0,,,1,,1.0,,,1.0,,,2,2.0,,,,1.0,,,,,,,1,1.0,,,,2.0,,1,,,1,,,5,,1,1,,,,7,1.0,34,2,,,,,,,,1.0,,,,,1.0,1.0,2,,6,,,,,2,,,,1,,,,,,,,,,,,2,2,,,2,,,,,,,,1.0,,,,,4,,,,,,,,,,,,,1,,,,,1,2,,1,2,,,,,,,,,1,,,,,4,,,,,,,7,,,8,,,5.0,,,,,,,,,2,,,,,1.0,,,,,,,,,4.0,,,,3.0,,,,,2,,4,,,,,2,,,9,,,4,,,,1,2.0,,3,,,,,7.0,,,3,,1.0,,,,,,4,4.0,,,,,,,2,,6,,,,1.0,,,,6.0,,,5,,,1.0,,,,,3,1,,4,,,,,,,,1.0,1.0,,,,,,5,4,,,,1.0,1.0,,1,,1.0,1.0,,,,,,,4.0,4.0,,3.0,,,,,2,,,,,,,2,,1.0,,1.0,,,,,2.0,,14,,1.0,,7,,,,1,,,1.0,,,,3.0,,,,2.0,,1,1.0,,3.0,,,1,,1.0,2.0,,,,,,,,,,1.0,,2,,,,,,2,3,,,2,,,2,,,,,,,,2,,,1.0,,,,,,,,,,,,2,3,,,1.0,5,,1.0,,,,,,,,,,,1,,,,8,,2,1.0,,1,4.0,,,,1.0,,1,,,,2.0,,,,,,5,1.0,,2,1.0,1.0,,,,,,,,,,,,,,,,,,,,,1.0,8.0,2.0,,,,,,2.0,,1.0,1,,,,1,1.0,,,,,4.0,,,6,,,,,,5,1.0,1.0,,5,,,,,,,2.0,2,1.0,2,,,,1.0,2.0,,1.0,3.0,3,,2,,3.0,1,1,,1.0,,1,,,,,,,,,,,,,,,,,,,4,15,,,,,,6,,,,,,1,,3,,2.0,,2.0,,,1.0,,3.0,3.0,,,,1,,,,,1.0,,,,2.0,,,,,,,,,,,,8,,,,1.0,,,,,,,,,4,1,,,,,,,,,,,1.0,,,1.0,,1,,4.0,4.0,5.0,2,2.0,6.0,4.0,,6,,2.0,,,,1,,,1.0,1,,,,,,3.0,,,,,3,,,,,,,,,1,,2.0,,2,4.0,1.0,,,,5,,,,,,4.0,6,,,1,,,,,,1,,,,,,,,,3.0,,,,,,1.0,,,,,,,,,,,,2,,,,,,1.0,,,3.0,,,1,1.0,,,,,,,1,,,,,,,1,,,,,3.0,14,,1.0,,,1.0,,,,,,,2.0,6,1.0,1.0,,,,,,,,,,,,,1,3.0,,,,,,,1,,4.0,1.0,3.0,,,,,,6,4.0,,2,2.0,,,1,,,1.0,,,1.0,,1.0,5,,,,1,2.0,,,,1.0,,,,,,4,,,,,,1,,,1.0,,,1.0,,,,,2.0,1.0,,,,,,,3,,,1.0,,1.0,,2.0,,,,,1.0,1.0,,,,,,,,,1.0,1.0,1.0,1.0,8.0,4.0,7.0,1.0,1.0,8.0,1.0,1.0,2.0,1.0,3.0,2.0,1.0,1.0,1.0,3.0,2.0,1.0,1.0,1.0,1.0,17.0,1.0,1.0,2.0,5.0,3.0,1.0,1.0,1.0,2.0,1.0,2.0,9.0,3.0,1.0,5.0,1.0,5.0,1.0,2.0,2.0,2.0,5.0,7.0,1.0,4.0,2.0,1.0,1.0,1.0,1.0,6.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,2.0,5.0,8.0,2.0,5.0,9.0,5.0,6.0,3.0,1.0,1.0,2.0,2.0,4.0,3.0,1.0,1.0,1.0,2.0,2.0,9.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,4.0,1.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,2.0,3.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,16.0,1.0,1.0,4.0,13.0,2.0,1.0,1.0,1.0,1.0,4.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,2.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,2.0,3.0,1.0,1.0,5.0,5.0,1.0,1.0,1.0,3.0,1.0,1.0,4.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,3.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,4.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,4.0,3.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,8.0,4.0,3.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,2.0,1.0,6.0,1.0,1.0,1.0,1.0,1.0,3.0,3.0,3.0,2.0,1.0,3.0,1.0,1.0,2.0,3.0,2.0,1.0,2.0,1.0,1.0,1.0,2.0,3.0,6.0,2.0,8.0,2.0,1.0,1.0,5.0,2.0,1.0,9.0,9.0,2.0,3.0,2.0,3.0,3.0,2.0,1.0,2.0,2.0,3.0,1.0,1.0,1.0,1.0,2.0,1.0,4.0,3.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,2.0,1.0,7.0,2.0,1.0,1.0,8.0,2.0,1.0,1.0,1.0,5.0,5.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,2.0,1.0,3.0,1.0,1.0,2.0,1.0,3.0,1.0,2.0,2.0,1.0,3.0,1.0,1.0,1.0,2.0,1.0,2.0,2.0,18.0,2.0,3.0,1.0,2.0,2.0,8.0,4.0,4.0,4.0,8.0,14.0,10.0,3.0,3.0,2.0,1.0,4.0,1.0,1.0,2.0,8.0,2.0,1.0,1.0,1.0,1.0,5.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,6.0,3.0,2.0,3.0,2.0,4.0,1.0,4.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,5.0,3.0,7.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,2.0,3.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,5.0,1.0,1.0,4.0,1.0,2.0,1.0,3.0,4.0,1.0,1.0,1.0,2.0,1.0,2.0,3.0,2.0,3.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,1.0,2.0,1.0,2.0,1.0,2.0,2.0,2.0,2.0,1.0,2.0,1.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,3.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,4.0,1.0,1.0,1.0,1.0,8.0,2.0,2.0,8.0,2.0,3.0,1.0,3.0,2.0,2.0,1.0,4.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,5.0,1.0,1.0,2.0,2.0,4.0,1.0,1.0,4.0,1.0,1.0,2.0,1.0,2.0,2.0,2.0,5.0,2.0,5.0,1.0,4.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,4.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,4.0,8.0,1.0,3.0,2.0,3.0,3.0,3.0,2.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,9.0,1.0,1.0,8.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,4.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,2.0,2.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,10.0,5.0,5.0,5.0,5.0,2.0,3.0,3.0,1.0,3.0,2.0,2.0,2.0,2.0,2.0,1.0,2.0,1.0,1.0,1.0,4.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,4.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,4.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,3.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,6.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,9.0,4.0,1.0,3.0,1.0,1.0,2.0,4.0,2.0,1.0,4.0,1.0,1.0,1.0,1.0,5.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,2.0,5.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,3.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,5.0,2.0,1.0,1.0,1.0,5.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,4.0,6.0,1.0,2.0,1.0,1.0,4.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,2.0,3.0,1.0,1.0,2.0,11.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,4.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,2.0,11.0,1.0,1.0,4.0,4.0,2.0,1.0,5.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,5.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,9.0,1.0,1.0,1.0,2.0,3.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,2.0,2.0,2.0,3.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,4.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,2.0,1.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,4.0,1.0,4.0,1.0,2.0,2.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,5.0,3.0,3.0,1.0,1.0,1.0,1.0,4.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,5.0,4.0,26.0,6.0,5.0,1.0,12.0,1.0,2.0,1.0,1.0,2.0,1.0,5.0,7.0,7.0,7.0,9.0,2.0,9.0,2.0,6.0,3.0,2.0,1.0,1.0,9.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,3.0,1.0,1.0,2.0,2.0,3.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,3.0,3.0,2.0,1.0,3.0,1.0,2.0,5.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,8.0,6.0,6.0,2.0,4.0,2.0,2.0,1.0,1.0,1.0,4.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,6.0,3.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
0,ВСТРЕТИЛОСЬ РАЗ в файле 2022.txt,24,,165,,,13,4.0,4,252,3,230,6,249,,14,5,3,4,11,2.0,29,8,,2,,,,,,38,1,24,,12,2,,4,8,1.0,55,1,,,6,2,,1.0,1,22,3,8,,,,,2.0,,,33,,,,,,15,2,,,2,3,75,,2,,,10,,7,,,17,,,,1,,,72,7,5,,,,,,1,2,1.0,1.0,7,1.0,,4,,2,,,,,,1,37,3,2,1,,,,7,27,,,,,1,,,,,,1,100,,,4,1.0,,10,1,,1,,,3,2,21,13,21,6,,10,,,2,,3,22,49,1.0,,,,,,,12,,6,,,,,1,1.0,,,2.0,2.0,,7,1,2,2,,,1.0,,,2,1.0,107,,,1,14,,,1.0,,7,,3,,,,,,,,5,,,,,,3,2,3,1,,16,,,,8,,,2,1,,,19,1,2,,,,3,2.0,9,3,,4,,4,2.0,,,,,,,14,2,13,,3,13,,5,4,,,1,,,1,1.0,,,,4,,2,,1.0,,,4,,4,3,1.0,22,7,,2,,,6,,2,1,,1,,1,,,,,,,,,,,4,,,,,,8,6,,15,2,,,1.0,,8,,,20,,2,,1,6,,1.0,1.0,1,,,,,,,,2,,,,,1.0,2.0,,,,3,1.0,1,,,1,,1,,,8,,3.0,2.0,,,17,,1.0,2,,,8,3,,,,,,1.0,,6,1,3,2.0,,,5,,,4,,,3.0,1,1,,,,10,,,1.0,2.0,12,,1,,,,1.0,1,,,6,,,2.0,,,7,3,,4,,,2,,,,,,,,,,,,1,3,,1.0,7,,,,,17,,,3,,,,,,1,1,,,,,,,2.0,,,,2.0,4,,,,,,1.0,,,,,6,,,,5,1,,,,6,,1,,1,2.0,2,,,4,2,,,,,3,,,1.0,2,4,5,3,,1,,1,,2,54,,3,,18,,5,,5,,,,,,2,1,,,,,,,,,9,1.0,5,14,,1.0,,8.0,1,,1.0,,,2,,,,,3,,,15,2,,,2,9,7,,,,,11,1,,,1.0,6,,,1.0,,,11,,3,1.0,1,9,6,6,,,,5,,,,,,,,1.0,,5,,,1.0,,,,,3,1,,6,10,,,,,,,1.0,,2.0,1.0,3,,,2,2,3,1.0,,1,,,1,3,,1.0,1.0,,1,,,1,2.0,10,,,,,,1,,,,,,,,,1,1,1.0,,,,,,1,,,,,,,,,,,3,1,,,,,,,8,5,3,,1,,,,,,,,,,3,1,2,,,2,,,,1,1,,1.0,,,2.0,,,,,,,,2,2,3,,,,,,2.0,,1.0,,1.0,,1.0,,,1,,1,3,,,1.0,1,,,,8,,,3.0,,7,1,2.0,,,2,4,4,,,9,,,,,,,1.0,1.0,,13,,,,,,12,,,,3,1,2,9,,4,,3,1,1.0,,2,1.0,,,,,,,,,,1.0,1,2,2,,13,3,,,,,10.0,,,,,,4,1,,,,6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6,3,2,2,2,1.0,1,2,,,,,,,,1.0,,,,,,,,,,,,,,8,,,,,,,,,,,2.0,,,,,,2.0,,,,,,,7,,,7,,,,,1,,1,,5.0,,,3,3,2,5,7,,,,1,4,7.0,1,,9,,,,1,5,,,,6,,8,,1,,1.0,5,1,2,,,2,2,6.0,,1.0,1,2,,11,2,3.0,3,,2,,1.0,10,1.0,2.0,3,3,2.0,,,,1.0,,2,1.0,1.0,,7,,,,1.0,4.0,,,,,1.0,,2,3.0,,,1,2,3.0,1,2.0,1.0,1,5,,3,1.0,1,,,12,1.0,7.0,1.0,,,,,2,,10.0,4,2,1,,,1.0,,,,1,,1,1.0,1,,6.0,1,1,,,,3.0,,2,,,2,,1,,,,6,,,2,,,,,,,2,4,1,,,3,,,,,,,,1.0,,1,,6,,1,2,,,,,,,,4,2,,,,2.0,,,,,,,,,,3,3,,,,,,,,1.0,3,1,,,2,,,,,,,,,3.0,,,,1.0,,,,,10,,4,5,,,1.0,5,,,,7.0,,1.0,,,,,,8,,,3,1,,8,3.0,1.0,,,,,,,,,,,,2,,,,,,1.0,,3,,,,,,,,,,,2,2,,,,,,,,,,,7.0,,2.0,1,,1.0,,,,,,,1,2.0,,,1.0,3,,,1,,,,1,2.0,,1.0,,,,1,,,2.0,1.0,,,,3,,,,,10,,,,1,,,,,2,,1.0,1,1,,1,,,1,,,,,,,,,,2,1,10,1,,,,,,1,,1,,,1,,,1.0,,,,,,,,1,,,,,2,2,,,,,,,,1.0,,1.0,1.0,,,2,,,,,,,2,1,,6,,,4,,3,,,,1,,,1,2,,,,,,5,,,,,,,,,1.0,,,,7,2,,,,2,1,,,,,,,,,1,,,,,,,,,,,,1,2.0,1,,,,,,,,,2,,,2,,,,,,,1.0,,,,,,,,,,,,,,,,,,,,,2,2,,,,,,,,,,4,5,,,,,,,,,,,,,7,2.0,2,1.0,1.0,,1.0,,4.0,,3,,,1.0,,,,,2,,,,1.0,,,,,,,,2,,,,,,2.0,3,,,1,,,2,,1,7,,2.0,,4,,6,2,,,5.0,12.0,1.0,2.0,1.0,,1.0,3.0,3.0,,,,2,5.0,18,,,,7.0,1,2.0,4.0,2.0,2,2.0,1.0,2.0,1.0,1.0,1.0,,,,,1.0,1,5,1.0,1.0,2,3.0,,1.0,,,,2.0,,,,,,1,,1.0,1.0,3.0,1.0,1.0,1.0,,,2.0,,,4,2.0,,2.0,1.0,2,1,1.0,2,2,,,,,,,,,1,1.0,,1.0,4.0,2,1.0,3.0,,,2.0,2.0,9,2.0,,12,,1.0,,,,,,,,,,3,,,,,,,,,,,,,,,,,,,,,,,22,1.0,2,,,,1.0,2,,,1,,2.0,3,1.0,,,2,,1.0,2,1.0,1.0,,,,,,1,,,,3.0,,,,3,,,,,1.0,,,1,,1,1.0,1.0,,,,,,,1.0,2.0,8,2.0,,,,,,,2,3,3.0,3,,,,,,,,,,,,,,,3,5,,,,,,,2,,,,,,,,,,,,,,,,,,2,,,,,,,1,,,,,,,,,,,3,,,,3,1.0,,,1,,,,,,,,,,,,,1,,,,,,4,,,,,,,,,,,,,,1.0,6,,,,,,3,1,3.0,,4,2.0,,2,,,,,,,,1,,,,1.0,,1.0,1.0,,2.0,,,,,,5,3,,,,1,1.0,,,,1.0,,2.0,,,,,,1,,,,1,,2,,,2,,,,,,,1,,,,,,,,3.0,,1,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,,,,4,,,,,,,4.0,,1,,,,1.0,,3,,,,1,,,,,,,,1,,1,,,3.0,,,,,,1,,1,,,2,3,1.0,,,2,3.0,1.0,,,1.0,,,,,,,5.0,2.0,,,,,,1,3,,,,,3.0,4,,,,,,2,,1,,,,,,,,,,,,,,1,,,,,,1.0,,,,,,,,,,,,,,,2,,1.0,1.0,,,,,,,,,,3,1,,,,,2.0,,,,,1.0,,,,,,1,,,,,2,,,,,5,,,,,,2,,,,2,,,,,,,,,,,1,1.0,,,,,,,,1,,,,2,,,,,,1,,,,,,,1,,,2,,,4.0,5.0,,2,,,,1.0,,,,,,,1.0,,,,,,,,,,4.0,,,1.0,,,1,,,,,,,,,,,,4,,,,,,,,6,,,,,3.0,,1,,,,,,3,1.0,,,,,,,,,,1.0,,5,,,,,,,,,1.0,,2.0,,,1.0,1,,,,,,,,1,,,,,,,,3.0,1.0,3,,1.0,2,,,,3,,2.0,,,,,,,1,1.0,,,1,,,,,,,,,,,1,,,,,,2,,,,,,,,,2.0,,,,,,,,,1.0,2,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,2.0,,,,,,,,,,,,,,,,,,,,3.0,,,,,1.0,3.0,,2.0,,,,,,,1.0,,,1.0,1.0,1.0,1.0,1.0,,,,,,,,2.0,,,,,,,2.0,,,,,,,4.0,,,,,,,1.0,2.0,,,,,,,,,,,,2.0,,,,,,,,,,,,,,,2.0,,,,,,,,,,,,,,,,,,,,,,,,3.0,,,,1.0,,,,,,,,,,,,,,,,,1.0,,,,,1.0,3.0,,,,,,,,3.0,,,,,,,,,,,,,,1.0,,,,,2.0,,,,,,,,4.0,,,,,,,,,,,,,,,,,,,1.0,,,,,1.0,,,,,,,2.0,,,,,,1.0,,,,,2.0,,1.0,1.0,,,,,,,,,,,,1.0,,,,1.0,,,,,2.0,,,,,,,,,,,,,,,,1.0,,,,,,,,,,1.0,,,2.0,,,,,,,,,,,,,,,,,1.0,,2.0,,,,,1.0,,,,,,,1.0,,2.0,,,,,,,,,,1.0,,,,,,,,,2.0,1.0,,4.0,2.0,,2.0,,,,,,,,,4.0,1.0,,1.0,,1.0,,,,,,,,1.0,,,,,,,,,,,,1.0,,,,,,,,,,,,,1.0,,,,,,,4.0,,,,,,,,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.0,,,1.0,,,,,,,1.0,3.0,,,,,1.0,,,,,,,1.0,,,1.0,4.0,,,1.0,,,,,,,,,,,,,,,,,,,,,1.0,1.0,,,,,2.0,,2.0,,,,,,,,,,,,,,,2.0,,,,1.0,,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,1.0,,,1.0,,,,,,,,,1.0,,,,,,,1.0,,,,1.0,,,,,,,,,1.0,,,6.0,1.0,1.0,1.0,,3.0,,1.0,3.0,,,2.0,1.0,1.0,2.0,,,,,,,,,,1.0,,,,,,,,,,,,1.0,,,2.0,,5.0,,1.0,,2.0,2.0,1.0,,,,,7.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.0,,1.0,4.0,12.0,,1.0,,,1.0,2.0,,,,,,,3.0,,,,,,,,,,,,,,,,1.0,,,3.0,,,,,,,,,,,,1.0,,,,,,,,,,1.0,,,,,,,,,,,,,,,,,,,,,,,,,5.0,2.0,,,,,1.0,,1.0,,,,,,,,,,,,,1.0,,,,,,,,,,,,,,,,,,,,,1.0,,,,,1.0,,,,,,,,,,,9.0,,1.0,,2.0,,,1.0,,,1.0,,,,,,1.0,1.0,,,,,,,,,,2.0,,,,10.0,,,,,,,3.0,,,,,,,,1.0,,,,,,2.0,,,2.0,,3.0,1.0,2.0,,,,,,,,,,,4.0,2.0,,,,,,,,,,,,,1.0,,2.0,,,,,,,,1.0,,,,,,,,,,,,,,2.0,,,,1.0,,,,1.0,,1.0,1.0,,,,6.0,1.0,1.0,,,1.0,,,,,,,,,,,,1.0,,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.0,,,,,,,,,,,,,,,1.0,1.0,,,,,,,,,,1.0,1.0,1.0,,,,,,,1.0,,,,,,,1.0,,,,,,,,,4.0,,,2.0,,,,,,,,,1.0,,,1.0,,,,,,,,,,,,,1.0,,,,,1.0,,,,,,,,,,,,,,,,,,2.0,,2.0,,1.0,,,,,,,1.0,,,,,,,,,,,6.0,,,,,,,,,,,,,,,,,,,,,,,,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,,,,,,,,,,,,,,,1.0,,,,,,,,,,,,,,,,,,,,2.0,,,,,,,1.0,,,,,,,,,,,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,,,,,,1.0,,,,,,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,,,,,,1.0,,,,1.0,,,,,,,,,,,,,,,,,,,,,2.0,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,,,,,4.0,,,,,,,,1.0,,,,,,,,,,,,1.0,,,,,,,,,,,,,1.0,,,,,,,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.0,,,,,1.0,,2.0,2.0,2.0,9.0,3.0,1.0,1.0,6.0,3.0,1.0,2.0,2.0,1.0,1.0,1.0,4.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,14.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,1.0,1.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,3.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,4.0,1.0,1.0,1.0,1.0,4.0,5.0,5.0,3.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,7.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,5.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,4.0,1.0,1.0,1.0,3.0,1.0,2.0,2.0,1.0,1.0,3.0,1.0,2.0,3.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,3.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,4.0,1.0,1.0,1.0,1.0,2.0,17.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,3.0,2.0,1.0,1.0,1.0,1.0,2.0,3.0,2.0,3.0,1.0,4.0,1.0,1.0,4.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,6.0,5.0,2.0,1.0,2.0,5.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,3.0,4.0,1.0,1.0,2.0,1.0,1.0,1.0,3.0,3.0,1.0,1.0,2.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,11.0,2.0,1.0,5.0,1.0,1.0,2.0,8.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,3.0,1.0,1.0,5.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,1.0,3.0,2.0,1.0,2.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,5.0,5.0,1.0,2.0,1.0,1.0,3.0,1.0,2.0,1.0,1.0,1.0,5.0,2.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,9.0,4.0,6.0,1.0,2.0,1.0,4.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,12.0,1.0,1.0,1.0,1.0,3.0,1.0,1.0,1.0,2.0,1.0,1.0,5.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,4.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,2.0,2.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,2.0,1.0,3.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,9.0,4.0,1.0,1.0,4.0,1.0,3.0,3.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,9.0,4.0,2.0,2.0,1.0,1.0,4.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,4.0,2.0,5.0,1.0,12.0,7.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,2.0,1.0,1.0,3.0,1.0,2.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,5.0,3.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,3.0,1.0,1.0,6.0,2.0,4.0,1.0,3.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,10.0,1.0,1.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,3.0,3.0,1.0,1.0,1.0,1.0,4.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0
